Navigation Links
Einstein researcher receives American Cancer Society Medal of Honor
Date:11/9/2010

November 5, 2010 (BRONX, NY) Albert Einstein College of Medicine of Yeshiva University researcher Jeffrey Pollard, Ph.D., has received the prestigious Medal of Honor in Basic Science from the American Cancer Society (ACS) in recognition of his research into the critical role the tumor microenvironment plays in modulating cancer behavior, specifically the role that members of the innate immune cells called macrophages play both in normal development and in promoting tumor progression. These macrophages could hold the key to more targeted cancer treatments.

Insights into how normal body cells support tumor growth have led the way to a new wave of research and the development of therapeutics specifically targeting the support cells in the body that can aid in tumor development. Dr. Pollard's research has found that when macrophages are removed from the tumor microenvironment, the risk of cancer progressing to malignancy is reduced and its spread from the primary tumor site to distant sites lessens.

"I think that one of the major components of the therapeutic arsenal as we go forward will be to combine chemo-therapeutic drugs with drugs that target macrophages so that they can no longer support the tumor's ability to be malignant," said Dr. Pollard. "Further it gives another opportunity for therapy by using vaccination against tumor antigens combined with altering macrophages from tumor promoting to tumor rejecting. It gives us another prong in the attack on cancer."

Dr. Pollard is deputy director of the Albert Einstein Cancer Center, director of the Center for Study of Reproductive Biology and Women's Health and the Louis Goldstein Swan Chair in Women's Cancer Research at Einstein. He is also professor in the departments of developmental and molecular biology and obstetrics & gynecology and women's health at Einstein and Montefiore Medical Center.

This award from the American Cancer Society, the nation's leading voluntary health organization and largest non-governmental investor in cancer research, represents the Society's highest honor in recognition of outstanding contributions to fighting cancer.

The award was presented at the American Cancer Society's annual meeting in Atlanta, GA. In addition to Dr. Pollard, the ACS recognized Joseph Fraumeni, M.D., M.Sc., for Cancer Control, and Patricia Ganz, M.D., for Clinical Research.

This is the second ACS Medal of Honor awarded to a researcher at the Albert Einstein Cancer Center. Susan Band Horwitz, Ph.D., received the Medal of Honor in 2008 for Clinical Research.


'/>"/>

Contact: Kim Newman
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Related biology news :

1. Einstein receives $30 million to study protein form and function
2. Einstein designated an NIH Center of Excellence for aging research
3. Einstein receives $4 million to test HPV microbicide
4. Einstein researcher awarded prestigious cancer research grant
5. Einstein-Montefiore research tackles childhood obesity in the Bronx
6. Einstein researchers discover 2 new ways to kill TB
7. Einstein receives high-risk/high-reward cancer research funding
8. Einstein to develop anti-HIV drug delivery system
9. Einstein scientists move closer to a safer anthrax vaccine
10. Einstein researchers devise a fast and sensitive way to detect ricin
11. NIH funds research center for womens reproductive health at Einstein
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC ... announced that the United States Patent and Trademark Office ... broadly covers the linking of an iris image with ... transaction) and represents the company,s 45 th issued ... patent is very timely given the multi-modal biometric capabilities ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
(Date:3/24/2017)... The Controller General of Immigration from Maldives Mr. Mohamed Anwar ... the prestigious international IAIR Award for the most innovative high security ePassport ... ... Maldives Immigration Controller General, Mr. ... on the right) have received the IAIR award for the "Most innovative ...
Breaking Biology News(10 mins):
(Date:5/16/2017)... ... May 16, 2017 , ... Genedata, a leading provider of ... User Group Meetings, which will be held in Boston, Cambridge/UK, Shanghai, and Tokyo. ... screening data analysis and learn about the latest advances in screening technologies and ...
(Date:5/16/2017)... ... May 16, 2017 , ... ... cancer diagnostics, has released its ClearID Lung Cancer blood test. Leveraging a highly-sensitive ... this new test is designed to quickly and accurately identify tumor-related genetic mutations ...
(Date:5/16/2017)... (PRWEB) , ... May 16, 2017 , ... On Tuesday, ... an ideal audience for introducing the advance in stem cell medicine that his company ... will be the second day of the Alliance for Regenerative Medicine’s first partnering conference, ...
(Date:5/15/2017)... ... 15, 2017 , ... Algenist is continuing to disrupt the ... cream with a patented formula, clinically proven to deliver visible firming results in ... Cream to our already innovative ELEVATE product line,” said vice president of product ...
Breaking Biology Technology: